MAPT and Parkinson disease: In the present prospective and longitudinal study, we investigated the CSF levels of tau, P‐tau, Aβ42, NFL, α‐syn, and YKL‐40 both at baseline and after 2 years of follow‐up in neurologically healthy elderly controls and patients with PD.